PATENT CLAIM ANALYSIS

Application Number: 15996140
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "04400R"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules comprising an mRNA encoding an OX40L polypeptide. Also provided is a method for activating T cells or increasing the number of NK cells in a subject in need thereof.

Claim (Index 22):
The method of  claim 18 , wherein the OX40L polypeptide comprises the amino acid sequence as set forth in SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 1.225
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15995889', '15996146', '15674569', '15425813', '15674585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8054958774643054
- 35 USC 102 Novelty (BERT): 0.6205424350111617
- Combined Prediction Score: 0.7870005332189911
- Mean Citation Score: 420.978798
- Max Citation Score: 612.70374
- Similarity Product: 501.2375033001495

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test